Get started
Author

Sujit V. Janardhan

Observed name: Sujit Janardhan
ORCID: 0000-0002-7146-7818
Observed ORCID: 0000-0002-7146-7818
OpenAlex ID: A5108474184
Con: Liver Biopsy Remains the Gold Standard to Evaluate Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
2019 · Daniel Berger, Vishal Desai, et al. · Clinical Liver Disease · 111
PDF
Broad Ligament Fibroid Mimicking as Ovarian Tumor on Ultrasonography and Computed Tomography Scan
2013 · Dayananda Kumar Rajanna, Vaibhav Pandey, et al. · Journal of Clinical Imaging Science · 41
Validation of a Clinical Risk-based Classification System in a Large Nonalcoholic Fatty Liver Disease Real-world Cohort
2023 · Arun J. Sanyal, Breda Munoz, et al. · Clinical Gastroenterology and Hepatology · 19
Safety and efficacy of continuous infusion terlipressin (BIV201): A phase 2 trial in patients with decompensated cirrhosis and refractory ascites
2025 · Jasmohan S. Bajaj, Ethan M. Weinberg, et al. · Liver Transplantation · 8
Common Misconceptions in Hepatology: Nonalcoholic Fatty Liver Disease
2019 · Sujit V. Janardhan · Clinical Liver Disease · 2
PDF
Safety and efficacy of continuous infusion terlipressin (BIV201) in patients with decompensated cirrhosis and refractory ascites: a phase 2, randomized, controlled, open-label study
2023 · Jasmohan Bajaj, Ethan Weinberg, et al. · Journal of Hepatology · 1
An Evaluation of an Advanced Practice Provider Led Weight Intervention in Liver Disease (WILD) Pathway
2023 · Sarah Repking, Karen Mayer, et al. · Gastroenterology Nursing · 1
S2583 Successful Implementation of MASH Screening Guidelines for Detection of Advanced Fibrosis in High-Risk Patients in a Primary Care Setting Using Electronic Health Record-Based Care Pathway Infrastructure
2025 · Brendan McQuillen, Sujit Janardhan, et al. · The American Journal of Gastroenterology
Editorial: Terlipressin Induced Bradycardia
2025 · Nancy Reau, Sujit Janardhan · Alimentary Pharmacology & Therapeutics
PDF
SAT-076 Patients with hepatorenal syndrome and lower baseline mean arterial pressure derive significant survival benefit from treatment with terlipressin
2024 · Paul Yien Kwo, Nikolaos T. Pyrsopoulos, et al. · Journal of Hepatology
S1477 The Effect of Terlipressin on Blood Pressure, Mean Arterial Pressure, and Heart Rate in Patients with Hepatorenal Syndrome: A Post Hoc Analysis of the CONFIRM Study
2023 · Jacqueline G. O’Leary, Nicholas Lim, et al. · The American Journal of Gastroenterology
S1096 Non-Alcoholic Fatty Liver Disease (NAFLD) Is an Underrecognized Comorbidity in Patients Presenting With Myocardial Infarction
2021 · Agnieszka M. Maniak, Sujit V. Janardhan, et al. · The American Journal of Gastroenterology
Tu1002 Non Liver Disease-Related Factors Significantly Impact “Liver Disease-Specific” Quality of Life Scores From the Chronic Liver Disease Questionnaire (CLDQ)
2014 · Sujit V. Janardhan, Jason Morris, et al. · Gastroenterology
Works count: 13
Citation count: 183
H-index: 4
I10-index: 3
Year
Topic
Type